How Cannabis Helps Crohn's Disease
CB2 receptors in the intestinal mucosa and immune cells mediate anti-inflammatory responses when activated by cannabinoids. THC reduces gut motility (beneficial during flares), decreases intestinal permeability, and has direct anti-inflammatory effects. CBD modulates intestinal immune responses and reduces pro-inflammatory cytokine production. The gut-endocannabinoid axis is now recognised as a core regulator of intestinal homeostasis. Anti-inflammatory cannabinoid effects are directly relevant to Crohn's pathophysiology. The terpene beta-caryophyllene acts as a selective CB2 agonist with targeted gut anti-inflammatory effects. Understanding the gut endocannabinoid system helps contextualise treatment rationale.
Clinical Evidence & Research
A 2013 clinical trial (Naftali et al.) — the first high-quality RCT for cannabis in Crohn's — found 45% of cannabis patients achieved complete remission versus 10% of placebo. A 2019 follow-up study showed significant improvement in Harvey-Bradshaw Index (disease activity) scores. Cannabis also significantly reduced Crohn's Disease Activity Index (CDAI) scores and improved quality of life. Israel leads global research in cannabis for Crohn's, with the Naftali group at Tel Aviv University conducting multiple landmark trials.
Access & Patient Requirements
Crohn's disease is a qualifying condition in approximately 25 US states. Documentation from a gastroenterologist is required, with evidence of established diagnosis and typically documentation of failed conventional treatment (mesalazine, steroids, biologics). California and New York include Crohn's explicitly. Israel and Germany permit medical cannabis for Crohn's in cases refractory to conventional therapy.
Recommended Cannabis Approaches for Crohn's
Full-spectrum cannabis oil is preferred for Crohn's as the complete cannabinoid and terpene profile maximises gut CB2 activation. During flares, higher-THC preparations reduce intestinal motility and pain. During remission, CBD-dominant products maintain anti-inflammatory tone without psychoactive effects. Some patients use suppositories or enemas with cannabis preparations for direct colonic delivery — particularly relevant for distal Crohn's. Pain relief effects and anti-inflammatory effects both contribute to Crohn's management. Avoid cannabis smoke, which can irritate respiratory mucosa and trigger systemic inflammation.